mcl0208: identification of novel genomic prognostic factors
Published 3 years ago • 62 plays • Length 5:36Download video MP4
Download video MP3
Similar videos
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
7:30
updates from juliet: correlative analyses and clinical characteristics associated with efficacy
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:44
the genomics of rt and prognostic implications of rt characterization
-
1:56
stellar: genomic sequencing of ctdna reveals additional driver mutations in richter's transformation
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
9:04
how are et, pv and myelofibrosis monitored?
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
6:07
novel prognostic index for pediatric all
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
1:07
the second revision of the international staging system for os in mm
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:03
insights into the cartitude-6 trial: rationale and design
-
3:21
an insight into the standard of care in hr-mds and future outlooks
-
3:23
molecular characteristics associated with increased risk of disease progression in smm